We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Huveaux | HVX | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 10.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.50 | 10.50 |
| Top Posts |
|---|
Posted at 08/3/2010 11:17 by pinkkasti Sunday Times ...Inside the city : Jenny DaveyHuveaux HUVEAUX had lofty ambitions when John van Kuffeler set it up to buy and build a business publishing empire in 2001. It lost its way and after profit warnings and slimming down, it is poised to become a tasty morsel for someone else. Last week Huveaux sold its education arm, including the Letts study guides, for £10m to Harper Collins. The deal will wipe out its outstanding debt. All that leaves is the political division, whose key assets are Dod's Parliamentary guides, The House magazine and various conferences. Huveaux, which has a market value of £15m, was in offer talks two years ago but to no avail. There have been grumblings from some investors about how it has been run since then. After Van Kuffeler departed, Kevin Hand, the former Emap boss, replaced him as chairman. His actions have left a company that is much more attractive to suitors. No wonder Schroders, which has 11% of the company, was topping up its stake last week. Mike Danson, the former owner of Datamonitor, also has a 23% holding. Danson has been mooted as a buyer but critics say his ownership of the left-wing New Statesman magazine makes him a bit too partisan to get involved in such publications - although it's hard to see how anyone could stop him. More likely, though, is that the company would make a good fit for Emap. The publisher already owns DeHavilland, the lobbyists' database. Observers think United Business Media could also be interested. There are no takeover talks for Huveaux at this stage - but, just like the build-up to D-Day in May for Brown and Cameron, the campaigning has begun. |
Posted at 28/4/2008 18:04 by crosswire Diary of a private investor: I feel more optimistic about the market Last Updated: 12:46am BST 26/04/2008 I'm doing just what the doctor ordered, writes James Bartholomew Thus encouraged, I have bought into two more companies which appear to me to be good value. I have significantly increased my stake in Huveaux, a company which produces educational, political, healthcare and other publications including the Letts school revision guides. The shares have had a horrid time. Last June they stood at 53p and it is as if they threw themselves off a cliff. They are now dazed and astonished down at 12p. Profits from healthcare publishing in France collapsed and spending on their products by the British government fell. Profits overall were hammered. On top of that, the company nearly went private but then did not. That meant some hopeful investors got burnt and they have doubtless been sellers. However, the company has put in cost-saving measures and won new contracts. I asked a friend of mine in publishing what sort of reputation the management had and he came back with a very positive response. Three brokers all forecast a good profits recovery which, if it comes to pass, will mean that shares are standing at less than six times prospective earnings per share. That sounds like good value to me. I have paid 11.5p per share for my increased stake. The major challenge has been to find similarly good value in the main stock market. There seem to be plenty of lowly valued companies in the Alternative Investment Market (Aim). |
Posted at 05/2/2007 11:22 by broomsticks We do mind your intrusion, this is a quiet thread for serious investors in Huveaux of which I am one. |
Posted at 09/11/2006 13:55 by broomsticks This snippet of information may be of interest. Title: HUVEAUX (HVX). Date: 3/10/2006; Publication: Investors Chronicle; Niche publishing has proved profitable for Huveaux, which has bounced back strongly from last year's profit warning. Acquisitions help explain the chunky rise in turnover, although sales also grew organically by 12.5 per cent. Its two key acquisitions, Epic and JBB Sante, have been integrated into the learning and healthcare divisions, respectively, and GBP2.1m of associated costs were absorbed in the full year. Epic is an e-learning specialist whose expertise will be used across all Huveaux's divisions, while French healthcare publisher JBB Sante was acquired in time for the introduction of mandatory medical education in France later this year. Huveaux's political arm enjoyed organic sales growth of 18 per cent as take-up of its political monitoring service, ePolitixPlus, continued in the UK and Brussels. Meanwhile, Huveaux is also delivering on its digital media strategy, which generated 28 per cent of turnover in 2005. COPYRIGHT 2006 FT Business What is really interesting in this article is, "Epic is an e-learning specialist whose expertise will be used across all Huveaux's divisions. Aimo, dyor |
Posted at 22/9/2006 22:14 by jlabrey From yesterday's Times:Corporate publisher Incisive Media rose 21.75p to 194.75p after agreeing to a £200 million bid from private equity firm Apax. Incisive's titles include Investment Week, Bloomberg Money, Insurance Age and the British Journal of Photography. The price -- at only 17 times next year's earnings, and a 13 per cent premium to the admittedly speculation-inflated stock -- looked a bit cheap compared with other deals in the sector, such as Euromoney's bid for Metal Bulletin. Some investors also noted that Incisive's board seemed to be doing extremely well out of the deal, selling two thirds of the their 7.7 per cent stake, retaining management positions and still ending up with nearly 12 per cent of the bidding company. ABN Amro's team did not expect a counter bid, because industry buyers such as Informa are unlikely to want Incisive's odd portfolio, any predator would have to win the backing of the management team. "We would therefore expect the offer to go through, albeit unenthusiastically," it said. Analysts were keener to talk about its rivals. "We expect Incisive to become a vehicle for further B2B consolidation by Apax, which currently has nothing in this space," said Dresdner Kleinwort. "This is likely to raise speculation over all the other small players in this space. eg Wilmington, Huveaux etc." ABN Amro argued that Wilmington and Centaur Media "stand out as the obvious targets, given significantly under-leveraged balance sheets, and in the case of Wilmington, the attractions of its position in relatively defensive growth markets." Centaur (titles: New Media Age, Marketing Week) was unchanged at 119p. Wilmington (Tunnels and Tunnelling, What Van?) rose 3.25p to 193.5p and Huveaux (The Parliament Magazine) took on 0.75p to 51.5p. |
Posted at 21/6/2006 15:00 by jeremyb Looking back over the last six months, at the amount of acquisitions of shares by directors and big investors, there seems to be only a positive future for this Company. The have more than doubled turnover each year for the past four and acquisitions have certainly kept profits down, but when the acquisitions are bedded in and turn into profits, the price must be on the way up. When people wake up to this one, the price will go back up to 60+. Interesting, but unnoticed at the moment. This is far too busy for this board - will look again in a month! The Wrong Price also likes this one |
Posted at 06/5/2006 19:26 by jlabrey An article in this week's Investors Chronicle suggests there may be a consolidation of the B2B publishing sector in the next year. This is the view both of Numis and Bridgewell. Huveaux wasn't mentioned specifically (bizarre, because it is the best value on P/E and growth basis) - the article referred to Incisive, Centaur, Metal Bulletin as well as the big boys such as UBM. HVX has the potential to create value in two ways that appeal to me: one through intellectual property in all divisions and second through cash generation. There is also the near certainty of earnings enhancing acquisitions. On a two year view I think Huveaux is superb value. |
Posted at 08/1/2006 22:15 by ckafetz Huveaux was tipped last Thursday. The day it went up a penny :Charles Stanley's Small-Cap Picks For 06 Thursday, January 05, 2006 5:25:19 AM ET Dow Jones Newswires 0907 GMT [Dow Jones] Small caps will continue to provide investors with opportunities in 06 but stock selection remains key, says Charles Stanley. Sees technology sector consolidation, whilst enterprise software and services should see overall spending growth of around 5%. Sees media remaining volatile with consumer confidence still weak. Sees continuing radio consolidation, more corporate activity in PR, development of mobile content side and expansion of independent television. Expects continued consolidation in Leisure. Picks AEA (AAT.LN) Compel (CGR.LN) Havelock (HVE.LN) Interserve (IRV.LN) Avanti (ASG.LN) Huveaux (HVX.LN) La Tasca (LAT.LN) and Wichford (WICH.LN). (DWE) |
Posted at 21/10/2005 19:03 by cerrito A question I ask myself as i wonder whether to add to my HVX holding bought earlier in the year after the profits warning, at sub 40.I see that volume has not been all that high in the last 2/3 weeks- higher than earlier in the year but now we have more shares. There must continue to be epic shareholders not happy with HVX's business model and who are selling. For all we know a.the original EPIC business may be going slowly...the Chairman's statement in July for Epic said things were satisfactory, and it was not all that upbeat b.problems with the integration of 2 new businesses c.People's concern as to whether the original HVX will deliver in this its peak season d.nothing for new investors to chew on, nothing to motivate someone to buy. The reality is that HVX has been more on promise than actual delivery. I have no great desire to buy more...may well be tempted if it goes a bit lower but enough belief in the basic thrust of HVX's political activities as well as Lonsdale to deter me from selling. |
Posted at 01/8/2005 10:47 by azalea Ah ha; so Framlington bought 2.6m Thursday/Friday last; who I wonder bought the other big chunks. Some answers below:DKW Securities and HBOS, with more to be announced I suspect to account for another conservative 2.5m, given the previous general disdain on this thread ( (rightly so after the FY) the rest being bought largely by well informed investors. I think the share price is taking a breather, however the end of the week could be interesting. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
